BNR:XETRA-Brenntag SE (EUR)

COMMON STOCK | Specialty Chemicals | XETRA

Last Closing Price

EUR 84.16

Change

0.00 (0.00)%

Market Cap

EUR 13.00B

Volume

0.19M

Avg Analyst Target

N/A

Avg User Target

EUR
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber material science industries. Brenntag SE was founded in 1874 and is based in Essen, Germany. Address: Messeallee 11, Essen, Germany, 45131

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-25 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN:XETRA Linde plc

N/A

EUR132.09B 54.42 16.17
SY1:XETRA Symrise AG

N/A

EUR16.64B 55.24 24.42
EVK:XETRA Evonik Industries AG

N/A

EUR13.62B 26.14 8.39
1COV:XETRA Covestro AG

N/A

EUR10.86B 12.69 5.86
LXS:XETRA LANXESS Aktiengesellschaft

N/A

EUR5.16B 5.83 3.74
FPE:XETRA Fuchs Petrolub SE

N/A

EUR5.15B 20.91 11.50
FPE3:XETRA Fuchs Petrolub SE

N/A

EUR5.15B 25.93 11.50
CE2:XETRA CropEnergies AG

N/A

EUR0.90B 10.35 5.68
UZU:XETRA Uzin Utz AG

N/A

EUR0.36B 17.36 6.91
ACT:XETRA AlzChem Group AG

N/A

EUR0.25B 10.83 5.24

ETFs Containing BNR

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.87% 100% A+ 90% A-
Dividend Return 2.13% 45% F 66% D
Total Return 35.00% 100% A+ 90% A-
Trailing 12 Months  
Capital Gain 53.74% 82% B- 87% B+
Dividend Return 2.47% 45% F 59% F
Total Return 56.21% 82% B- 88% B+
Trailing 5 Years  
Capital Gain 84.22% 73% C 79% C+
Dividend Return 10.29% 50% F 44% F
Total Return 94.51% 73% C 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 9.73% 73% C 71% C-
Dividend Return 1.74% 55% F 70% C-
Total Return 11.47% 73% C 76% C
Risk Return Profile  
Volatility (Standard Deviation) 29.11% 36% F 24% F
Risk Adjusted Return 39.42% 73% C 47% F
Market Capitalization 13.00B 75% C 87% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.93 33% F 45% F
Price/Book Ratio 3.47 17% F 39% F
Price / Cash Flow Ratio 10.67 42% F 45% F
EV/EBITDA 13.09 25% F 50% F
Management Effectiveness  
Return on Equity 12.32% 33% F 64% D
Return on Invested Capital 10.39% 58% F 74% C
Return on Assets 4.82% 42% F 72% C-
Debt to Equity Ratio 41.45% 42% F 58% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.12 50% F 26% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector